Tizona Therapeutics

Improving outcomes for people with cancer

South San Francisco, United States · Founded 2014 · $370.0M raised

Employees
11–50
Founded
2014
Business Model
B2B
Total Funding
$370.0M
Last Round
$300.0M Corporate RoundJul 2020
Rounds
3

About

Tizona Therapeutics is a clinical-stage immunotherapy company applying novel scientific insights to change the course of cancer progression and relapse. Founded in 2014 and headquartered in South San Francisco, California, Tizona has advanced two first-in-class immune checkpoint therapeutics into the clinic, with a strategic alliance with Gilead Sciences supporting its lead program TTX-080.

Summary

Tizona Therapeutics is a Biotech company based in South San Francisco, United States, founded in 2014. It has raised $370.0M in total across 3 rounds, most recently a $300.0M Corporate Round in Jul 2020. Investors include Gilead Sciences, Canaan Partners and Abingworth Bioventures.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Corporate RoundCorporate RoundJul 2020
$300.0M

Sign up to see all 3 events

Funding: Series A through Corporate Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Tizona Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/tizona-therapeutics"><img src="https://indexed.vc/api/badge/company/tizona-therapeutics" alt="Tizona Therapeutics on Indexed.vc" width="260" height="76" /></a>